Fundz

Who to call at Neurogene, and when

Fundz watches for the moments Neurogene starts buying, and tells you who to reach.

  • An alert the day Neurogene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurogene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurogene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchNeurogene Inc. announces positive interim data for NGN-401 gene therapy aimed at treating Rett syndrome.

Nov 11, 2024
New YorkOtherBiotechnologyHealth CareTherapeutics

Product Description

Neurogene Inc. has reported positive interim clinical data from the first four participants in the low-dose cohort of its clinical trial for NGN-401 gene therapy, showcasing meaningful gains in skills and developmental milestones in pediatric patients with Rett syndrome.

Company Information

Company

Neurogene

Location

New York, New York, United States

About

Neurogene Inc. is a clinical-stage company dedicated to bringing life-changing genetic medicines to patients and families affected by rare neurological diseases. The company focuses on developing novel approaches and treatments to overcome the limitations of conventional gene therapy in central nervous system disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurogene ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Julie hidden

hidden
hidden

Ricardo hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Neurogene's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Neurogene shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.